APA (7th ed.) Citation

S, K., AM, F., S, T., LN, C., ME, B., T, G., . . . K, W. (2025). A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer. Clinical breast cancer, 25(3), 251. https://doi.org/10.1016/j.clbc.2024.11.019

Chicago Style (17th ed.) Citation

S, Kamaraju, et al. "A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer." Clinical Breast Cancer 25, no. 3 (2025): 251. https://doi.org/10.1016/j.clbc.2024.11.019.

MLA (9th ed.) Citation

S, Kamaraju, et al. "A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer." Clinical Breast Cancer, vol. 25, no. 3, 2025, p. 251, https://doi.org/10.1016/j.clbc.2024.11.019.